Jianxia Liu Selected Research

Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)

8/2010

The Kringle-2 domain of tissue plasminogen activator significantly reduces mortality and brain infarction in middle cerebral artery occlusion rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianxia Liu Research Topics

Disease

5	Neoplasms (Cancer) 08/2021 - 03/2018
2	Triple Negative Breast Neoplasms 05/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Plasmacytoma 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 08/2021
1	Atherosclerosis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Multiple Sclerosis 12/2020
1	Neoplasm Metastasis (Metastasis) 03/2018
1	Trigger Finger Disorder (Finger, Snapping) 01/2018
1	Heart Failure 01/2018
1	Hyperoxia 07/2017
1	Cardiomegaly (Heart Hypertrophy) 04/2016
1	Reperfusion Injury 12/2012
1	Ischemia 12/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2010
1	Brain Infarction 08/2010
1	Brain Ischemia (Cerebral Ischemia) 08/2010

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 01/2021 - 12/2012
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 03/2018 - 04/2016
1	asparaginylendopeptidase (legumain)IBA 08/2021
1	MicroRNAs (MicroRNA)IBA 08/2021
1	CateninsIBA 05/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	PlatinumIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2020
1	teriflunomideIBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2018
1	isomangiferinIBA 03/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2018
1	Histones (Histone)IBA 01/2018
1	Local AnestheticsIBA 01/2018
1	CytokinesIBA 07/2017
1	Myelin Basic ProteinIBA 07/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2017
1	EstersIBA 07/2017
1	Messenger RNA (mRNA)IBA 04/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2010

Therapy/Procedure

2	Transplantation 05/2021 - 12/2012
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2021
1	Analgesia 01/2018